The transcriptional activity of ER (or NR3A1) after binding of ligand is mediated through synergistic action between activation functions (AFs) AF-1 and AF-2 and the transcriptional machinery. This is functionally achieved by bridging coactivators such as CEBP binding protein/p300 and members of the p160 subfamily such as steroid receptor coactivator protein-1 (SRC-1). We previously identified a conserved potential -helical structure within the AF-1 functional core, and by evaluating point mutants of human ER (hER) within this region, we show that in transfection experiments this structure is required for synergism between SRC-1 and hER. We report that the transcriptional synergism between AF-1 mutants and SRC-1 was abolished in AF-1-sensitive cells such as HepG2, whereas it was reduced by 50% in CHO-K1 cells, which have a mixed context that is sensitive to both the AF-1 and AF-2 regions of hER. Glutathione-S-transferase pulldown assays demonstrate that the AF-1 core is able and sufficient for the hER N-terminal region to interact with SRC-1. Interestingly, an enhancement of this recruitment in the presence of the hER ligand-binding domain was observed, which was found to be dependent on a direct interaction between the N-terminal B domain and the ligand-binding domain. Another functional consequence of this physical interaction, which is promoted by both partial and full agonists of hER, was an increase in the phosphorylation state of the N-terminal domain. Binding of 4-hydroxytamoxifen (OHT) to the hER C-terminal region induced a functional AF-1 conformation in vitro through this N-and C-terminal interaction. The involvement of an SRC-1-mediated pathway in transactivation mediated by hER AF-1 was further substantiated by transfection experiments using the OHTresponsive human C3 promoter, which showed that OHT-induced hER AF-1 activity was enhanced by SRC-1 and required the AF-1 -helical structure. In conclusion, we demonstrate that the synergism between AF-1 and AF-2 is mediated in part by a cooperative recruitment of SRC-1 by both the AF-1 -helical core and AF-2 regions and that it is stabilized by a direct interaction between the B and C-terminal domains. This interaction of SRC-1 with the AF-1 -helical core is essential for both E2-and OHT-induced ER activity. (Molecular Endocrinology 15: 1953-1970, 2001) E STROGENS ARE POWERFUL regulators of both the developmental and functional aspects of reproductive functions (1). Estrogens are also involved in proliferative reproductive disorders, notably in breast and endometrium cancers (2-4). E2-regulated processes are predominantly transduced at the transcriptional level and are mediated by two related receptors, termed ER and ER (NR3A1 and NR3A2, respec-tively) (5). Both are ligand-inducible transcription factors (6, 7). ERs belong to the highly diverse superfamily of nuclear receptors (NRs), which are structurally organized into six independent domains, termed A to F, each of which encodes specific functions (8-10; Fig. The NR signature motif is the cysteine-rich, zinccoordinated structure of the C domain, which mediates binding to DNA (11-13). The C-terminal region, also termed the ligand-binding domain (LBD), is organized into 10-13 -helices (14, 15). ERs have two major transcriptional regulatory functions, activation function 1 (AF-1) at the N terminus and AF-2 at the C terminus. AF-2 can be further subdivided into AF-2 core and AF-2a transactivating regions (16-19; Fig. These AFs exhibit distinct transactivation properties that depend on both cell and promoter contexts (20, 21). The full transcriptional activity of the ERs is
No takes yet. Share an insight, caveat, or question.
Métivier et al. (2001) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: